Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors | |
Alternative Title | Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors |
Zhao DongMei1; Li WenYan1; Shi YuFang2; Xiong XuQiong1; Song Shuai1; Hao ChenZhou1; Cheng MaoSheng1; Shen JingKang2 | |
2014 | |
Source Publication | CHINESE CHEMICAL LETTERS
![]() |
ISSN | 1001-8417 |
Volume | 25Issue:2Pages:299-304 |
Abstract | Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that plays an important role in decreasing high-density lipoprotein cholesterol (HDL-C) levels and increasing low-density lipoprotein cholesterol (LDL-C) levels. Inhibition of CETP may be a new therapy for treating atherosclerosis. Herein, we report the development of a ligand-based pharmacophore model and pharmacophore-based virtual screening of the ZINC/big-n-greasy database, leading to the identification of compound H-10 as a potential CETP inhibitor in vitro. Based on H-10, a series of 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides were designed, synthesized, and evaluated against CETP. Compound 41 was found to have the best activity, resulting in 85.0% inhibition of CETP at 10 mu mol/L. (C) 2013 Mao-Sheng Cheng and Jing-Kang Shen. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved. |
Other Abstract | Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that plays an important role in decreasing high-density lipoprotein cholesterol (HDL-C) levels and increasing low-density lipoprotein cholesterol (LDL-C) levels. Inhibition of CETP may be a new therapy for treating atherosclerosis. Herein, we report the development of a ligand-based pharmacophore model and pharmacophore-based virtual screening of the ZINC/big-n-greasy database, leading to the identification of compound H-10 as a potential CETP inhibitor in vitro. Based on H-10, a series of 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides were designed, synthesized, and evaluated against CETP. Compound 4l was found to have the best activity, resulting in 85.0% inhibition of CETP at 10 μmol/L. |
Keyword | CHIRAL N,N-DISUBSTITUTED TRIFLUORO-3-AMINO-2-PROPANOLS POTENT INHIBITORS DISCOVERY TRANSPORT Cholesteryl ester transfer protein CETP inhibitors Pharmacophore Virtual screening Synthesis |
Indexed By | CSCD |
Language | 英语 |
CSCD ID | CSCD:5059654 |
Citation statistics | |
Document Type | 期刊论文 |
Identifier | http://ir.imr.ac.cn/handle/321006/148150 |
Collection | 中国科学院金属研究所 |
Affiliation | 1.中国科学院金属研究所 2.Shanghai Pharmaceut Holding Co Ltd, Cent Res Institute, Shanghai 201203, Peoples R China |
Recommended Citation GB/T 7714 | Zhao DongMei,Li WenYan,Shi YuFang,et al. Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors[J]. CHINESE CHEMICAL LETTERS,2014,25(2):299-304. |
APA | Zhao DongMei.,Li WenYan.,Shi YuFang.,Xiong XuQiong.,Song Shuai.,...&Shen JingKang.(2014).Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors.CHINESE CHEMICAL LETTERS,25(2),299-304. |
MLA | Zhao DongMei,et al."Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors".CHINESE CHEMICAL LETTERS 25.2(2014):299-304. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment